Figure 1: Antibody design to improve homogeneity ... Thus, decreasing costs is an important part of drug development. The IgG-based biotherapeutic agents that have been approved in the past ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback